Dominant Mutans Streptococci Genetic Strains in Caries-Active Children

龋齿活跃儿童中的显性变形链球菌遗传株

基本信息

  • 批准号:
    9136362
  • 负责人:
  • 金额:
    $ 10万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-09-15 至 2018-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Dental caries represents one of the most common chronic diseases affecting young children, and is a multi-factorial disease involving complex interactions of risk factors. The mutans streptococci (MS) group is among the most cariogenic microorganisms associated with dental caries. We propose to identify the microbial factors affecting the genetic diversity and potential selection of MS strains following caries restorative therapy in children. In prior work, we described genetic fingerprints of MS isolates (N=828) collected before and after treatment from children exhibiting severe early childhood caries (S-ECC). We have also identified the dominant MS genetic strains that occur in carious and non-carious sites within the oral cavity of individual patients (N=20), and have characterized strain cariogenicity properties. Our published studies have identified 39 MS genetic strains, and have found that caries restorative therapy in some patients results in population shifts to highly acidogenic or acid-tolerant MS strains, with single dominant MS strains appearing at 1-year post-therapy. The objectives of this current project are to initiate a new cohort of 250 patients where restorative and adjunctive therapy measures can be applied independently to ascertain selective effects, determine if MS genetic strains with distinct cariogenicity profiles undergo preferred selection in carious sites versus non-carious sites within the oral cavity of individual patients, and develop a standardized genetic database of MS variants with defined cariogenic phenotypes that may serve as predictive microbial identifiers for dental caries and treatment outcomes. The study hypothesis is that children with S-ECC may possess distinct genetic strains of MS, which undergo resistance and/or selection during specific aspects of caries restorative treatment, and this impact the effectiveness and long-term outcome of the treatment. The translational goal of this project will be to provide insight on the efficacy of restorative an adjunctive therapy practices in the elimination and/or reduction of certain MS genetic strains in caries-active children. The significance of this study is profound, as treatment in some patients with S-ECC results in the appearance of dominant and highly-cariogenic MS genetic strains, which conceivably could place the patient at even higher risk. This study is innovative because of its potential to predict the outcome of caries preventive therapy based on the identification of the MS genetic strains. The OHSU School of Dentistry is an eligible institution for an R15 AREA award. The Principal Investigator and collaborative faculty group have mentored over 13 graduate dental residents, 30 dental students and 18 undergraduate students in research over the past 5 years, and we anticipate continued success in the recruitment of new student researchers for the R15 award.
描述(由申请人提供):龋齿代表影响幼儿的最常见慢性疾病之一,是一种涉及危险因素复杂相互作用的多因素疾病。 Mutans链球菌(MS)组是与龋齿相关的最大的致癌微生物之一。我们建议确定影响儿童龋齿恢复治疗后MS菌株的遗传多样性和潜在选择的微生物因素。在先前的工作中,我们描述了从表现出严重的幼儿龋齿(S-ECC)的儿童治疗前后收集的MS分离株(n = 828)的遗传指纹。我们还确定了在单个患者口腔内的龋齿和非狂热部位中发生的主要MS遗传菌株(n = 20),并且具有菌株性致癌性的特征。我们已发表的研究已经确定了39毫秒的遗传菌株,并发现某些患者的龋齿恢复治疗会导致种群转移到高度酸性或耐酸的MS菌株,并在治疗后1年出现单个显性MS菌株。 The objectives of this current project are to initiate a new cohort of 250 patients where restorative and adjunctive therapy measures can be applied independently to ascertain selective effects, determine if MS genetic strains with distinct cariogenicity profiles undergo preferred selection in carious sites versus non-carious sites within the oral cavity of individual patients, and develop a standardized genetic database of MS variants with defined cariogenic phenotypes that may serve作为龋齿和治疗结果的预测微生物标识符。该研究假设是S-ECC患者可能具有MS的不同遗传菌株,在龋齿恢复治疗的特定方面会受到抵抗和/或选择,这会影响治疗的有效性和长期结果。该项目的翻译目标将是对恢复性的辅助治疗实践的有效性,以消除和/或减少龋齿活性儿童的某些MS遗传菌株。这项研究的意义是深远的,因为在某些S-ECC患者中的治疗导致出现显性且高度钙化的MS遗传菌株,这可以想象可以使患者处于更高的风险。这项研究具有创新性,因为它有潜力根据鉴定龋齿预防疗法的结果 MS遗传菌株。 OHSU牙科学校是R15地区奖的合格机构。在过去的5年中,这家首席调查员和合作教师小组在研究中指导了13多名研究生牙科居民,30名牙科学生和18名本科生研究,我们预计在招募新的学生研究人员R15奖中将继续取得成功。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Adjunctive dental therapies in caries-active children: Shifting the cariogenic salivary microbiome from dysbiosis towards non-cariogenic health.
  • DOI:
    10.1016/j.humic.2020.100077
  • 发表时间:
    2020-12-01
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Lyashenko, Claudia;Herrman, Elisa;Machida, Curtis A
  • 通讯作者:
    Machida, Curtis A
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CURTIS A MACHIDA其他文献

CURTIS A MACHIDA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CURTIS A MACHIDA', 18)}}的其他基金

Dominant Mutans Streptococci Genetic Strains in Caries-Active Children
龋齿活跃儿童中的显性变形链球菌遗传株
  • 批准号:
    8687956
  • 财政年份:
    2014
  • 资助金额:
    $ 10万
  • 项目类别:
bZIP Repression of Adrenergic Receptor RNA in Neurons
bZIP 抑制神经元中肾上腺素能受体 RNA
  • 批准号:
    6917675
  • 财政年份:
    2005
  • 资助金额:
    $ 10万
  • 项目类别:
bZIP Repression of Adrenergic Receptor RNA in Neurons
bZIP 抑制神经元中肾上腺素能受体 RNA
  • 批准号:
    7027080
  • 财政年份:
    2005
  • 资助金额:
    $ 10万
  • 项目类别:
?1 ADRENERGIC RECEPTOR ACTIVATION & EXPRESSION
?1 肾上腺素能受体激活
  • 批准号:
    6592300
  • 财政年份:
    2002
  • 资助金额:
    $ 10万
  • 项目类别:
Adrenergic Receptor Mechanisms in Antidepressant Therapy
抗抑郁治疗中的肾上腺素受体机制
  • 批准号:
    6685266
  • 财政年份:
    2002
  • 资助金额:
    $ 10万
  • 项目类别:
GENETIC DIVERSITY OF SIMIAN RETROVIRUSES
猿逆转录病毒的遗传多样性
  • 批准号:
    6592299
  • 财政年份:
    2002
  • 资助金额:
    $ 10万
  • 项目类别:
Adrenergic Receptor Mechanisms in Antidepressant Therapy
抗抑郁治疗中的肾上腺素受体机制
  • 批准号:
    6580613
  • 财政年份:
    2002
  • 资助金额:
    $ 10万
  • 项目类别:
NUCLEOCYTOPLASM EXPORT OF SIMIAN RETROVIRUS RNA GENET ELEMENT & PROTEIN FAC:AIDS
猿逆转录病毒RNA基因元件的核质输出
  • 批准号:
    6592301
  • 财政年份:
    2002
  • 资助金额:
    $ 10万
  • 项目类别:
NUCLEOCYTOPLASM EXPORT OF SIMIAN RETROVIRUS RNA GENET ELEMENT & PROTEIN FAC:AIDS
猿逆转录病毒RNA基因元件的核质输出
  • 批准号:
    6453677
  • 财政年份:
    2001
  • 资助金额:
    $ 10万
  • 项目类别:
GENETIC DIVERSITY OF SIMIAN RETROVIRUSES
猿猴逆转录病毒的遗传多样性
  • 批准号:
    6453675
  • 财政年份:
    2001
  • 资助金额:
    $ 10万
  • 项目类别:

相似国自然基金

面向康复护理机器人的人机信任度评估方法与任务影响机制研究
  • 批准号:
    62306195
  • 批准年份:
    2023
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
长期护理保险制度与老年照护供给效率及公平:影响机制与政策措施
  • 批准号:
    72274117
  • 批准年份:
    2022
  • 资助金额:
    45.00 万元
  • 项目类别:
    面上项目
长期护理保险制度与老年照护供给效率及公平:影响机制与政策措施
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    45 万元
  • 项目类别:
    面上项目
深海土阻力时变特性影响下管线轴向走管的变形机理及防护理论研究
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
深海土阻力时变特性影响下管线轴向走管的变形机理及防护理论研究
  • 批准号:
    52101325
  • 批准年份:
    2021
  • 资助金额:
    24.00 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Discovery of early immunologic biomarkers for risk of PTLDS through machine learning-assisted broad temporal profiling of humoral immune response
通过机器学习辅助的体液免疫反应的广泛时间分析发现 PTLDS 风险的早期免疫生物标志物
  • 批准号:
    10738144
  • 财政年份:
    2023
  • 资助金额:
    $ 10万
  • 项目类别:
Investigating metabolism and DNA damage repair in uropathogenic Escherichia coli fluoroquinolone persisters
研究泌尿道致病性大肠杆菌氟喹诺酮类持续存在的代谢和 DNA 损伤修复
  • 批准号:
    10747651
  • 财政年份:
    2023
  • 资助金额:
    $ 10万
  • 项目类别:
Project 2
项目2
  • 批准号:
    10731714
  • 财政年份:
    2023
  • 资助金额:
    $ 10万
  • 项目类别:
Sex Effects for Hearing Loss Drug Therapies
性对听力损失药物治疗的影响
  • 批准号:
    10791076
  • 财政年份:
    2023
  • 资助金额:
    $ 10万
  • 项目类别:
Advancing Development of Novel Immunotherapy for Chemotherapy-induced Peripheral Neuropathy (CIPN)
推进化疗引起的周围神经病变 (CIPN) 的新型免疫疗法的发展
  • 批准号:
    10588384
  • 财政年份:
    2023
  • 资助金额:
    $ 10万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了